Your browser doesn't support javascript.
loading
GRN Mutations Are Associated with Lewy Body Dementia.
Reho, Paolo; Koga, Shunsuke; Shah, Zalak; Chia, Ruth; Rademakers, Rosa; Dalgard, Clifton L; Boeve, Bradley F; Beach, Thomas G; Dickson, Dennis W; Ross, Owen A; Scholz, Sonja W.
Afiliación
  • Reho P; Neurodegenerative Diseases Research Unit, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland, USA.
  • Koga S; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.
  • Shah Z; Neurodegenerative Diseases Research Unit, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland, USA.
  • Chia R; Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland, USA.
  • Rademakers R; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.
  • Dalgard CL; VIB Center for Molecular Neurology, Antwerp, Belgium.
  • Boeve BF; Department of Anatomy, Physiology & Genetics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
  • Beach TG; The American Genome Center, Collaborative Health Initiative Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
  • Dickson DW; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Ross OA; Banner Sun Health Research Institute, Sun City, Arizona, USA.
  • Scholz SW; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.
Mov Disord ; 37(9): 1943-1948, 2022 09.
Article en En | MEDLINE | ID: mdl-35810449
BACKGROUND: Loss-of-function mutations in GRN are a cause of familial frontotemporal dementia, and common variants within the gene have been associated with an increased risk of developing Alzheimer's disease and Parkinson's disease. Although TDP-43-positive inclusions are characteristic of GRN-related neurodegeneration, Lewy body copathology has also been observed in many GRN mutation carriers. OBJECTIVE: The objective of this study was to assess a Lewy body dementia (LBD) case-control cohort for pathogenic variants in GRN and to test whether there is an enrichment of damaging mutations among patients with LBD. METHODS: We analyzed whole-genome sequencing data generated for 2591 European-ancestry LBD cases and 4032 neurologically healthy control subjects to identify disease-causing mutations in GRN. RESULTS: We identified six heterozygous exonic GRN mutations in seven study participants (cases: n = 6; control subjects: n = 1). Each variant was predicted to be pathogenic or likely pathogenic. We found significant enrichment of GRN loss-of-function mutations in patients with LBD compared with control subjects (Optimized Sequence Kernel Association Test P = 0.0162). Immunohistochemistry in three definite LBD cases demonstrated Lewy body pathology and TDP-43-positive neuronal inclusions. CONCLUSIONS: Our findings suggest that deleterious GRN mutations are a rare cause of familial LBD. © 2022 International Parkinson Movement Disorder Society. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad por Cuerpos de Lewy / Progranulinas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Mov Disord Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad por Cuerpos de Lewy / Progranulinas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Mov Disord Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos